Related Experiment Video
Updated: Jun 11, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
Quality control of phenotypic forms data in the Type 1 Diabetes Genetics Consortium
Letitia H Perdue1, Lotte Albret, Alan Aldrich
1Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA. lperdue@wfubmc.edu
Background:
When collecting phenotypic data in clinics across the globe, the Type 1 Diabetes Genetics Consortium (T1DGC) used several techniques that ensured consistency, completeness, and accuracy of the data.
Purpose:
The aim of this article is to describe the procedures used for collection, entry, processing, and management of the phenotypic data in this international study.
Methods:
The T1DGC ensured the collection of high quality data using the following procedures throughout the entire study period. The T1DGC used centralized and localized training, required a pilot study, certified all data entry personnel, created standardized data collection forms, reviewed a sample of form sets quarterly throughout the duration of the study, and used a data entry system that provided immediate feedback to those entering the data.
Results:
Due to the intensive procedures in developing the forms, the study was able to uphold consistency among all clinics and minimal changes were required after implementation of the forms. The train-the-trainer model was efficient and only a small number of clinics had to repeat a pilot study. The study was able to maintain a low percentage of missing data (<0.001%) and low duplicate data entry error rate (0.10%).
Conclusions:
It is critical to provide immediate follow-up in order to reinforce training and ensure the quality of the data collected and entered.
Related Concept Videos
Type I Diabetes I: Introduction
Incomplete Dominance
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pedigree Analysis
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
